Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "CheckMate 238 Trial - Adjuvant Nivo vs. Ipi in Resected Stage III/IV Melanoma"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Paolo A. Ascierto
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Paolo A. Ascierto
Login to view comments.
Click here to Login
Skin